Gilead Sciences Ownership | Who Owns Gilead Sciences?


OverviewForecastRevenueFinancialsChartTranscripts

Gilead Sciences Ownership Summary


Gilead Sciences is owned by 82.21% institutional investors, 0.12% insiders, and 17.68% retail investors. Blackrock is the largest institutional shareholder, holding 9.67% of GILD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.13% of its assets in Gilead Sciences shares.

GILD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockGilead Sciences82.21%0.12%17.68%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryDrug Manufacturers - General Stocks56.05%0.09%43.86%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock120.63M9.67%$8.28B
Vanguard group115.26M9.24%$7.91B
Capital world investors76.25M6.11%$5.23B
Capital research global investors60.43M4.85%$4.15B
State street59.33M4.76%$4.07B
Dodge & cox33.12M2.66%$2.27B
Geode capital management26.97M2.16%$1.85B
Wellington management group llp22.94M1.84%$1.57B
Morgan stanley19.34M1.55%$1.33B
Fmr18.48M1.48%$1.27B

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sarissa capital management lp1.10M12.78%$75.70M
Sector gamma as420.16K10.77%$28.83M
Cutter capital management, lp292.96K6.07%$20.10M
Mccarthy asset management130.36K5.27%$8.94M
Westend capital management138.64K3.80%$12.81M
F&v capital management155.33K3.78%$14.35M
Twin lakes capital management76.21K3.57%$5.23M
Sicart associates105.93K3.50%$9.78M
Foundation resource management207.72K3.20%$19.19M
Verity & verity378.10K3.19%$34.93M

Top Buyers

HolderShares% AssetsChange
Norges bank17.39M0.18%17.39M
Pacer advisors6.43M1.28%5.65M
Wellington management group llp22.94M0.28%2.37M
Amundi11.24M0.29%1.74M
State street59.33M0.18%1.62M

Top Sellers

HolderShares% AssetsChange
Capital world investors76.25M0.85%-8.25M
Citadel advisors278.39K0.00%-5.04M
Nuveen asset management4.99M0.10%-3.58M
Voloridge investment management---2.38M
Blackrock120.63M0.19%-1.90M

New Positions

HolderShares% AssetsChangeValue
Norges bank17.39M0.18%17.39M$1.19B
Mirae asset global etfs1.06M0.17%1.06M$72.76M
Jennison associates943.63K0.05%943.63K$87.16M
J. safra sarasin838.14K1.05%838.14K$57.49M
Corebridge financial391.70K0.15%391.70K$26.87M

Sold Out

HolderChange
Mendota financial group-3.00
Country trust bank-3.00
Cypress capital management llc (wy)-5.00
Mfa wealth advisors-13.00
Cypress capital-13.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241,7401.05%1,025,105,383-1.03%821.19%7841.69%673-0.30%
Jun 30, 20241,691-3.92%1,032,995,9351.04%821.23%7591.61%663-9.80%
Mar 31, 20241,760-3.40%1,022,412,986-1.81%811.18%747-14.14%7356.99%
Dec 31, 20231,8225.44%1,041,305,6482.03%831.25%8708.34%68710.10%
Sep 30, 20231,728-0.86%1,020,607,071-1.78%811.18%8037.64%624-11.86%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv39.07M3.13%-71.75K
Vanguard Institutional 500 Index Trust33.75M2.71%274.98K
American Funds Income Fund of Amer A29.58M2.37%-1.59M
Invesco QQQ Trust25.28M2.03%275.54K
Dodge & Cox Stock I24.35M1.95%-24.30K
Capital Group Wash Mutual Invtrs Comp21.53M1.73%-1.00M
American Funds Washington Mutual A21.53M1.73%-1.00M
SPDR® S&P 500® ETF Trust15.60M1.25%117.28K
Fidelity 500 Index15.38M1.23%104.53K
iShares Core S&P 500 ETF14.63M1.17%10.29K

Recent Insider Transactions


DateNameRoleActivityValue
Jan 15, 2025Dickinson Andrew D Chief Financial OfficerSell$228.38K
Dec 16, 2024Dickinson Andrew D Chief Financial OfficerSell$781.66K
Nov 29, 2024Dickinson Andrew D Chief Financial OfficerSell$11.20M
Nov 29, 2024Dickinson Andrew D Chief Financial OfficerSell$11.87M
Nov 27, 2024Parsey Merdad Chief Medical OfficerSell$8.11M

Insider Transactions Trends


DateBuySell
2024 Q4-13
2024 Q3-6
2024 Q2-1
2024 Q1-4
2023 Q4-1

GILD Ownership FAQ


Who Owns Gilead Sciences?

Gilead Sciences shareholders are primarily institutional investors at 82.21%, followed by 0.12% insiders and 17.67% retail investors. The average institutional ownership in Gilead Sciences's industry, Drug Manufacturers - General Stocks, is 56.05%, which Gilead Sciences exceeds.

Who owns the most shares of Gilead Sciences?

Gilead Sciences’s largest shareholders are Blackrock (120.63M shares, 9.67%), Vanguard group (115.26M shares, 9.24%), and Capital world investors (76.25M shares, 6.11%). Together, they hold 25.03% of Gilead Sciences’s total shares outstanding.

Does Blackrock own Gilead Sciences?

Yes, BlackRock owns 9.67% of Gilead Sciences, totaling 120.63M shares as of Jun 2024. This represents 0.19% of BlackRock's total assets, with a market value of 8.28B$. In the last quarter, BlackRock decreased its holdings by -1.899M shares, a -1.55% change.

Who is Gilead Sciences’s biggest shareholder by percentage of total assets invested?

Sarissa capital management lp is Gilead Sciences’s biggest shareholder by percentage of total assets invested, with 12.78% of its assets in 1.1M Gilead Sciences shares, valued at 75.7M$.

Who is the top mutual fund holder of Gilead Sciences shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Gilead Sciences shares, with 3.13% of its total shares outstanding invested in 39.07M Gilead Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools